Congress introduce bill to restrict manufacture of GLP1s.

I just saw a single vial of T100 for $268.
I just did a group buy of Uther T100 for $220. For 10 vials.
That's 12 times less.

Update: The email said $268, but the website says $291.
$218.25 if you buy 3+, though. What a bargain!
 
Last edited:
That is practically free compared to reta kits at Cain's new sister site. The larger-dose kit has a $1,000 markup compared to Nexaph ($850 for 48-mg kit at Nexaph vs. $1850 at EZPeptides):
I'm pretty impressed with Grey Axis. Right now they have a kit of R30 for 310 dollars. That's a better deal that Nexaph's R24 preorder for 300. Grey also has an R50 kit for 498.00. Cain and his sister site are probably selling plenty though, those prices wouldn't be so high if people weren't paying them.
 
I'm pretty impressed with Grey Axis. Right now they have a kit of R30 for 310 dollars. That's a better deal that Nexaph's R24 preorder for 300. Grey also has an R50 kit for 498.00. Cain and his sister site are probably selling plenty though, those prices wouldn't be so high if people weren't paying them.
$1+ a gram for reta is a good way to support a vendor.
 
They seem to be really over-reacting.

Not knowing anything, I would venture that sales were already dropping (for the overpriced/ripoff resellers), so risk tolerance was lessening. Or someone they all know was busted or some other insider info.
 
Last edited:
They seem to be really over-reacting.

Not knowing anything, I would venture that sales were already dropping, so risk tolerance was lessening. Or someone they all know was busted or some other insider info.
I mean there are two ways the soon to be new law plays out:
Either it's written narrowly such that compounding pharmacies only get in trouble if they sell "counterfeit" products that are fully reconstituted OR they decide that the law applies to anyone selling "counterfeit" GLP1-related products and nail domestic sellers with running an unlicensed pharmacy (and whatever additional charges might apply there) while they're at it.

If I was in their shoes I wouldn't want to take the gamble on which way it plays out. Not sure how old you are, but it feels strangely reminiscent of back in the day when the RIAA went after Napster (and other file sharing services).

If 5% to 10% of users are going through non-pharma channels, they probably wouldn't care, but when it's gotten to the point where Tiktok users are actively encouraging Lilly's potential customer base to buy elsewhere, pharma is going to put their full weight behind crushing the non-official US supply chain to whatever extent they're able to.
 
If I was in their shoes I wouldn't want to take the gamble on which way it plays out. Not sure how old you are, but it feels strangely reminiscent of back in the day when the RIAA went after Napster (and other file sharing services).

If 5% to 10% of users are going through non-pharma channels, they probably wouldn't care, but when it's gotten to the point where Tiktok users are actively encouraging Lilly's potential customer base to buy elsewhere, pharma is going to put their full weight behind crushing the non-official US supply chain to whatever extent they're able to.
Selling sema at $10 a mg is sleazy anyway (as with Kimera Chems for a vial of sema 5 mg), so good riddance.

These guys are all with public websites, so Cain will just get more business, including maybe even his EZPeptides site with reta 48-mg kits for over $1800. Until he ever gets busted, wisely retires, or stops having a very public website.

Cain seems invincible, so far, though so did Napster. But one way the Napster situation was different was that every young person was using it.
 
Last edited:
Top Bottom